↓ Skip to main content

Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles

Overview of attention for article published in International Journal of Nanomedicine, April 2015
Altmetric Badge

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles
Published in
International Journal of Nanomedicine, April 2015
DOI 10.2147/ijn.s77405
Pubmed ID
Authors

Chean Yeah Yong, Swee Keong Yeap, Kok Lian Ho, Abdul Rahman Omar, Wen Siang Tan

Abstract

Influenza A virus poses a major threat to human health, causing outbreaks from time to time. Currently available vaccines employ inactivated viruses of different strains to provide protection against influenza virus infection. However, high mutation rates of influenza virus hemagglutinin (H) and neuraminidase (N) glycoproteins give rise to vaccine escape mutants. Thus, an effective vaccine providing protection against all strains of influenza virus would be a valuable asset. The ectodomain of matrix 2 protein (M2e) was found to be highly conserved despite mutations of the H and N glycoproteins. Hence, one to five copies of M2e were fused to the carboxyl-terminal end of the recombinant nodavirus capsid protein derived from Macrobrachium rosenbergii. The chimeric proteins harboring up to five copies of M2e formed nanosized virus-like particles approximately 30 nm in diameter, which could be purified easily by immobilized metal affinity chromatography. BALB/c mice immunized subcutaneously with these chimeric proteins developed antibodies specifically against M2e, and the titer was proportional to the copy numbers of M2e displayed on the nodavirus capsid nanoparticles. The fusion proteins also induced a type 1 T helper immune response. Collectively, M2e displayed on the nodavirus capsid nanoparticles could provide an alternative solution to a possible influenza pandemic in the future.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 2%
Unknown 57 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 19%
Student > Master 10 17%
Student > Ph. D. Student 9 16%
Researcher 5 9%
Student > Doctoral Student 4 7%
Other 7 12%
Unknown 12 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 22%
Agricultural and Biological Sciences 10 17%
Immunology and Microbiology 8 14%
Medicine and Dentistry 3 5%
Engineering 3 5%
Other 7 12%
Unknown 14 24%